Literature DB >> 26163585

An Epistatic Interaction between Themis1 and Vav1 Modulates Regulatory T Cell Function and Inflammatory Bowel Disease Development.

Christophe Pedros1, Guillaume Gaud1, Isabelle Bernard1, Sahar Kassem1, Marianne Chabod1, Dominique Lagrange1, Olivier Andréoletti2, Anne S Dejean1, Renaud Lesourne1, Gilbert J Fournié1, Abdelhadi Saoudi3.   

Abstract

The development of inflammatory diseases depends on complex interactions between several genes and various environmental factors. Discovering new genetic risk factors and understanding the mechanisms whereby they influence disease development is of paramount importance. We previously reported that deficiency in Themis1, a new actor of TCR signaling, impairs regulatory T cell (Treg) function and predisposes Brown-Norway (BN) rats to spontaneous inflammatory bowel disease (IBD). In this study, we reveal that the epistasis between Themis1 and Vav1 controls the occurrence of these phenotypes. Indeed, by contrast with BN rats, Themis1 deficiency in Lewis rats neither impairs Treg suppressive functions nor induces pathological manifestations. By using congenic lines on the BN genomic background, we show that the impact of Themis1 deficiency on Treg suppressive functions depends on a 117-kb interval coding for a R63W polymorphism that impacts Vav1 expression and functions. Indeed, the introduction of a 117-kb interval containing the Lewis Vav1-R63 variant restores Treg function and protects Themis1-deficient BN rats from spontaneous IBD development. We further show that Themis1 binds more efficiently to the BN Vav1-W63 variant and is required to stabilize its recruitment to the transmembrane adaptor LAT and to fully promote the activation of Erk kinases. Together, these results highlight the importance of the signaling pathway involving epistasis between Themis1 and Vav1 in the control of Treg suppressive function and susceptibility to IBD development.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26163585     DOI: 10.4049/jimmunol.1402562

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Proteomic Analysis of Regulatory T Cells Reveals the Importance of Themis1 in the Control of Their Suppressive Function.

Authors:  Fanny Duguet; Marie Locard-Paulet; Marlène Marcellin; Karima Chaoui; Isabelle Bernard; Olivier Andreoletti; Renaud Lesourne; Odile Burlet-Schiltz; Anne Gonzalez de Peredo; Abdelhadi Saoudi
Journal:  Mol Cell Proteomics       Date:  2017-04-03       Impact factor: 5.911

2.  Interpretable network-guided epistasis detection.

Authors:  Diane Duroux; Héctor Climente-González; Chloé-Agathe Azencott; Kristel Van Steen
Journal:  Gigascience       Date:  2022-02-04       Impact factor: 6.524

Review 3.  Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.

Authors:  Ye Shu; Qinghua Hu; Hai Long; Christopher Chang; Qianjin Lu; Rong Xiao
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 4.  Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.

Authors:  Christophe Pedros; Fanny Duguet; Abdelhadi Saoudi; Marianne Chabod
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

5.  Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells.

Authors:  Andreas Kyburz; Angela Fallegger; Xiaozhou Zhang; Aleksandra Altobelli; Mariela Artola-Boran; Timothy Borbet; Sabine Urban; Petra Paul; Christian Münz; Stefan Floess; Jochen Huehn; Timothy L Cover; Martin J Blaser; Christian Taube; Anne Müller
Journal:  J Allergy Clin Immunol       Date:  2018-09-19       Impact factor: 10.793

Review 6.  Negative times negative equals positive, THEMIS sets the rule on thymic selection and peripheral T cell responses.

Authors:  Suzanne Mélique; Cui Yang; Renaud Lesourne
Journal:  Biomed J       Date:  2022-03-26       Impact factor: 7.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.